Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus

Nature Immunology(2025)10.1038/s41590-024-02041-2Source: DataRank Database

β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus is a research paper published in Nature Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 50 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 18.68)OA: hybridTopics (58)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Kim A. Tran ORCID,Raphael Chevre ORCID,Veronica Locher ORCID,Mathis Richter ORCID,Sarah Sun

Live enrichment

PubMed:39779870 PMC:PMC11785525 OpenAlex:https://openalex.org/W4406179562

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases

Grant: AI160406

NIAID NIH HHS

Grant: T32 AI007090

Gates Foundation

Grant: INV-003360

NIAID NIH HHS

Grant: U01 AI160406

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 7U01AI160406-03

Targeting trained immunity and Th1/Th17 axis with combination adjuvants

FWCI

18.68

Citation Percentile

1.0%

Influential Citations

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.nature.com/articles/s41590-024-02041-2.pdf

HYBRIDhttps://doi.org/10.1038/s41590-024-02041-2

publisherhttps://www.nature.com/articles/s41590-024-02041-2.pdf

publisherhttps://www.nature.com/articles/s41590-024-02041-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39779870

Fields of Study

Immune responses and vaccinationsNeutrophil, Myeloperoxidase and Oxidative MechanismsImmune cells in cancerMedicineBiology03 medical and health sciences0302 clinical medicineAnimalsNeutrophilsbeta-GlucansOrthomyxoviridae InfectionsInfluenza A virusMiceImmune ToleranceMice, Inbred C57BLImmunity, InnateLungInterleukin-10Mice, KnockoutHumansInterferon Type I

MeSH Terms

AnimalsHematopoietic Stem CellsHumansImmune ToleranceImmunity, InnateInterferon Type ILungMice, Inbred C57BLNeutrophilsOrthomyxoviridae InfectionsInfluenza A virusInterleukin-10Mice, Knockoutbeta-GlucansMice

Keywords

VirusDiseaseVirologyImmunologyBiologyMicrobiologyMedicineMice, Knockoutbeta-GlucansNeutrophilsArticleImmunity, InnateInterleukin-10Mice, Inbred C57BLMiceOrthomyxoviridae InfectionsInfluenza A virusInterferon Type IImmune ToleranceAnimalsHumansLung

Sustainable Development Goals

SDG 0: Good health and well-being